W92-26671-32415
2 vaccinations
3 coded responses
7 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 951 / CA
- Registered
- 2022-09-15
- Relationship
- Child or adolescent in my care
- Guardian
- J54-83606-75340
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-08-12
Dose 1 — Pfizer-BioNTech
-
2022-09-02
Dose 2 — Pfizer-BioNTech
-
2022-09-15
Registered in v-safe
- 2022-09-16
-
2022-09-23
Survey response — day 21, dose 2, under 3MedDRA: Nasal congestion, Nasopharyngitis — Feeling: FairFree text: Nasal congestion, likely a cold.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Survey response — day 28, dose 2, under 3MedDRA: Unevaluable event — Feeling: FairFree text: First tooth!MedDRA releases: 2024-11 · check-in free text available
- 2022-10-07
- 2022-10-14
- 2022-12-02
-
2023-03-04
Survey response — 6 months, dose 2, under 3MedDRA: Cough, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-12 | Pfizer-BioNTech | No |
| 2 | 2022-09-02 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Nasal congestion, likely a cold.
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: First tooth!
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release